Tag Archives: Simon Xi

Lundbeck, Rgenta Therapeutics partner over discovery of small molecules targeting RNA regulation and splicing of disease-causing genes

(PRESS RELEASE) VALBY, 4-Aug-2021 — /EuropaWire/ — Lundbeck (CPH: LUN), a Danish international pharmaceutical company, has announced it will partner with Rgenta Therapeutics, Cambridge, MA-based developer of oral, small-molecule RNA-targeting medicines with an initial focus on oncology, to discover small … Read the full press release